United States Self-Monitoring Blood Glucose Market Size (2024 - 2029)

The United States self-monitoring blood glucose market is projected to experience significant growth over the forecast period, driven by the increasing need for effective diabetes management solutions. The market's expansion is influenced by the rising awareness of the importance of blood glucose monitoring in preventing severe health complications associated with diabetes. The integration of innovative technologies, such as digital health apps and automated insulin management systems, is enhancing patient care and self-management capabilities, thereby contributing to the market's growth. These advancements are expected to improve health outcomes for diabetes patients, further boosting the market's potential.

Market Size of United States Self-Monitoring Blood Glucose Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
United States Self-Monitoring Blood Glucose Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 7.62 Billion
Market Size (2029) USD 10.38 Billion
CAGR (2024 - 2029) 6.40 %

Major Players

United States Self-Monitoring Blood Glucose Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

US Self-Monitoring Blood Glucose Market Analysis

The United States Self-Monitoring Blood Glucose Market size is estimated at USD 7.62 billion in 2024, and is expected to reach USD 10.38 billion by 2029, growing at a CAGR of 6.40% during the forecast period (2024-2029).

According to the CDC, routine diabetes management was important to reduce the risk of bad health outcomes and severe COVID-19 in diabetes patients. However, the pandemic caused disruptions in diabetes management, a worsening of glycemic control, and more cases of severe diabetic ketoacidosis. Between April and August 2020, about 60% of people who were just diagnosed with type 1 diabetes had diabetic ketoacidosis as their first sign or symptom.This is about twice as many as in previous years, which suggests that people with diabetes are taking longer to seek care and get diagnosed. During the COVID-19 pandemic, glycemic control got better when people used telemedicine or checked their own blood sugar.

Blood glucose monitoring increases patients' awareness of glucose values, which supports healthy lifestyle choices. Blood Glucose Monitoring values help in providing feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.

According to the National Center for Health Statistics, approximately 32.8% of adults aged 18 and over in the United States will be obese in 2021. When a person is overweight, their fat cells release chemicals that cause inflammation. These chemicals may make the body less sensitive to the insulin it makes by messing up the way insulin-responsive cells work. So, these people need insulin shots from the outside and have to use a device like a glucometer to check their blood sugar.

Innovative technologies, such as digital health apps that show and summarize each person's blood glucose readings and add other relevant data like insulin doses, meals or snacks, and physical activity, can help people better manage their own diabetes while reducing the burden of the disease and improving care overall. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are all new developments that give patients with poorly controlled diabetes the extra help they need to improve critical outcomes, which will improve the market's prospects in the years to come.

US Self-Monitoring Blood Glucose Industry Segmentation

Diabetic patients can measure their own blood sugar levels using a glucometer, test strips, and lancets by self-monitoring their blood glucose.Based on the readings, patients can adjust or check the effect of their treatment. The United States self-monitoring blood glucose market is segmented into components (glucometer devices, test strips, and lancets). The report offers the value (in USD million) and volume (in million units) for the above segments.

Component (Value and Volume, 2017 - 2028)
Glucometer Devices
Test Strips
Lancets
Need A Different Region Or Segment?
Customize Now

United States Self-Monitoring Blood Glucose Market Size Summary

The United States self-monitoring blood glucose market is poised for significant growth over the forecast period, driven by the increasing prevalence of diabetes and the rising demand for effective diabetes management solutions. The market is characterized by the integration of innovative technologies, such as digital health apps and advanced glucometers, which enhance patient engagement and facilitate better management of blood glucose levels. These advancements are crucial in preventing complications associated with uncontrolled diabetes, such as renal, nerve, and ocular damage. The market's expansion is further supported by the growing awareness of the importance of routine diabetes management, especially in the wake of disruptions caused by the COVID-19 pandemic, which highlighted the need for effective self-monitoring solutions.

The market landscape is moderately fragmented, with key players like Abbott, LifeScan, and Ascensia holding significant shares. The test strips segment dominates the market due to its recurring use and essential role in blood glucose testing. Reimbursement policies, such as those offered by Medicare, play a vital role in driving market growth by covering diabetic supplies and equipment. The introduction of connected devices and platforms by startups and established companies alike is expected to enhance the market's prospects, offering patients more comprehensive tools for managing their condition. As the market continues to evolve, the focus on socioeconomic factors and health disparities remains critical, with various organizations advocating for policies that address these issues to improve diabetes outcomes across diverse populations.

Explore More

United States Self-Monitoring Blood Glucose Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Component (Value and Volume, 2017 - 2028)

      1. 2.1.1 Glucometer Devices

      2. 2.1.2 Test Strips

      3. 2.1.3 Lancets

United States Self-Monitoring Blood Glucose Market Size FAQs

The United States Self-Monitoring Blood Glucose Market size is expected to reach USD 7.62 billion in 2024 and grow at a CAGR of 6.40% to reach USD 10.38 billion by 2029.

In 2024, the United States Self-Monitoring Blood Glucose Market size is expected to reach USD 7.62 billion.

United States Self-Monitoring Blood Glucose Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)